We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

4SC Announces First-in-Man Phase I Results for 4SC-203

News   Jan 09, 2011

 
4SC Announces First-in-Man Phase I Results for 4SC-203
 
 
Advertisement
 

RELATED ARTICLES

Computer Model Finds the Right Balance for Parkinson's Medication

News

As Parkinson's disease progresses, more levodopa is required to treat it. Too much, however, can lead to uncontrollable, involuntary bodily movements. To better understand the underlying reasons behind these effects, researchers created a model of the interactions between levodopa, dopamine, and the brain.

READ MORE

New Cancer Drug Targeting DNA Repair Shows Promise in Early-Stage Trial

News

A new precision drug which stops cancer from repairing its DNA has shown promise in an early-stage clinical trial – highlighting the potential of a new class of drugs known as ATR inhibitors.

READ MORE

Phase 3 Trial Assesses Dual-Antibody Injection's Ability To Prevent SARS-CoV-2 Infection

News

A Phase III, randomized, double-blinded, placebo-controlled trial will help to determine if the dual-antibody treatment, REGN-COV2, can prevent infection in individuals who share a home with someone who has been diagnosed with COVID-19.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE